Intra-immusg Pte Ltd

This study tests a new drug called PRL3-zumab in adults with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug can slow tumor growth or shrink tumors. About 51 participants will receive the drug, and researchers will track how …

This study tests a drug called PRL3-zumab in 60 adults with advanced solid tumors that have not responded to standard treatments. The drug is given by IV every two weeks and aims to slow or stop tumor growth by targeting a protein found in many cancers. Researchers will monitor s…